NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Rinri Therapeutics

Rinri Therapeutics

Private
SheffieldHealthcare & Life Scienceshttps://www.rinri-therapeutics.com/

Last Round

Grant

Oct 2, 2025

Total Funding Raised

$31.74M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Rinri Therapeutics is a biotechnology company developing first-in-class regenerative cell therapies to restore hearing by repairing damaged sensory cells in the inner ear.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicinestem cell therapycell therapysensorineural hearing lossATMPadvanced therapy medicinal producthearing loss treatmenthearing restorationauditory neuron regenerationbiotechclinical trialsallogeneic cell therapydrug discoverybiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rinri Therapeutics Comparables

Compare Rinri Therapeutics with similar companies based on industry and business-model similarity.

Rinri Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Rinri Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 2, 2025
Series AJan 14, 2025
GrantMay 13, 2021
SeedMay 20, 2019

Key People

Founding team and executive leadership

Simon Chandler

CEO And Director

Executive Team

Terri Gaskell

Chief Technology Officer

Executive Team

Rinri Therapeutics Investors

Notable investors and investment history

Rinri Therapeutics investors
InvestorRounds
UCB VenturesGrant, Series A, Seed
Pioneer GroupSeries A
British Business BankGrant
UCB VenturesGrant, Seed
Innovate UKGrant
J.P. Morgan Asset ManagementGrant
Boehringer Ingelheim Venture FundGrant, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 2, 2025

    $1M grant received.

  • Oct 2, 2025

    Attended the 2nd Annual Life Sciences Innovation Summit on October 2, 2025.

Rinri Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rinri Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rinri Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSheffield
Employee Range21
Year Founded2018
Last FundingOct 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.